Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure.

Premature ovarian failure (POF) is characterized by hypergonadotropic hypogonadism and amenorrhea before the age of 40. The condition has a heterogeneous background but genetic factors are demonstrated by the occurrence of familial cases. We identified a mother and daughter with POF both of whom carry an X;autosome translocation [t(X;11)(q24;q13)]. RNA expression studies of genes flanking the X-chromosome breakpoint revealed that both patients have reduced expression levels of the gene Progesterone Receptor Membrane Component-1 (PGRMC1). Mutation screening of 67 females with idiopathic POF identified a third patient with a missense mutation (H165R) located in the cytochrome b5 domain of PGRMC1. PGRMC1 mediates the anti-apoptotic action of progesterone in ovarian cells and it acts as a positive regulator of several cytochrome P450 (CYP)-catalyzed reactions. The CYPs are critical for intracellular sterol metabolism, including biosynthesis of steroid hormones. We show that the H165R mutation associated with POF abolishes the binding of cytochrome P450 7A1 (CYP7A1) to PGRMC1. In addition, the missense mutation attenuates PGRMC1's ability to mediate the anti-apoptotic action of progesterone in ovarian cells. These findings suggest that mutant or reduced levels of PGMRC1 may cause POF through impaired activation of the microsomal cytochrome P450 and increased apoptosis of ovarian cells.

[1]  A. Shelling Premature ovarian failure. , 2010, Reproduction.

[2]  A. Rajkovic,et al.  Transcription factor FIGLA is mutated in patients with premature ovarian failure. , 2008, American journal of human genetics.

[3]  J. Peluso,et al.  Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations. , 2008, Endocrinology.

[4]  A. Rajkovic,et al.  NOBOX homeobox mutation causes premature ovarian failure. , 2007, American journal of human genetics.

[5]  M. Cahill Progesterone receptor membrane component 1: An integrative review , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  M. Bard,et al.  Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. , 2007, Cell metabolism.

[7]  J. Peluso,et al.  Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism. , 2006, The Journal of clinical endocrinology and metabolism.

[8]  M. Skinner,et al.  Interactions between progesterone and tumor necrosis factor-alpha in the regulation of primordial follicle assembly. , 2006, Reproduction.

[9]  J. Peluso,et al.  Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action. , 2006, Endocrinology.

[10]  S. Bione,et al.  Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. , 2006, Human reproduction.

[11]  R. A. Goldbeck,et al.  Spectroscopic and biochemical characterization of heme binding to yeast Dap1p and mouse PGRMC1p. , 2005, Biochemistry.

[12]  G. Vinson,et al.  Molecular identification of adrenal inner zone antigen as a heme‐binding protein , 2005, The FEBS journal.

[13]  Peter Gustavsson,et al.  Loss of ZDHHC15 expression in a woman with a balanced translocation t(X;15)(q13.3;cen) and severe mental retardation , 2005, European Journal of Human Genetics.

[14]  D. Kleinjan,et al.  Long-range control of gene expression: emerging mechanisms and disruption in disease. , 2005, American journal of human genetics.

[15]  J. Peluso,et al.  Progesterone Regulates Granulosa Cell Viability Through a Protein Kinase G-Dependent Mechanism That May Involve 14-3-3σ1 , 2004, Biology of reproduction.

[16]  P. Beck‐Peccoz,et al.  Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. , 2004, American journal of human genetics.

[17]  J. Peluso,et al.  Involvement of an unnamed protein, RDA288, in the mechanism through which progesterone mediates its antiapoptotic action in spontaneously immortalized granulosa cells. , 2004, Endocrinology.

[18]  N. Horike,et al.  Characterization of the adrenal-specific antigen IZA (inner zone antigen) and its role in the steroidogenesis , 2004, Molecular and Cellular Endocrinology.

[19]  E. Jabs,et al.  Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome , 2004, Nature Genetics.

[20]  R. Laxová,et al.  The critical region on the human Xq , 1990, Human Genetics.

[21]  D. Russell The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.

[22]  R. Schiffmann,et al.  Ovarian failure related to eukaryotic initiation factor 2B mutations. , 2003, American journal of human genetics.

[23]  G. Schotta,et al.  Position-effect variegation and the genetic dissection of chromatin regulation in Drosophila. , 2003, Seminars in cell & developmental biology.

[24]  C. Gillberg,et al.  A candidate region for Asperger syndrome defined by two 17p breakpoints , 2003, European Journal of Human Genetics.

[25]  M. Sowers,et al.  Premature menopause in a multi-ethnic population study of the menopause transition. , 2003, Human reproduction.

[26]  A. Bateman,et al.  Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain , 2002, Genome Biology.

[27]  W. Umek,et al.  Genetic disorders in premature ovarian failure. , 2002, Human reproduction update.

[28]  D. Schlessinger,et al.  The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome , 2001, Nature Genetics.

[29]  Ann E. Taylor,et al.  Systemic Adversities of Ovarian Failure , 2001, Journal of the Society for Gynecologic Investigation.

[30]  A. Zinn,et al.  The X Chromosome and the Ovary , 2001, Journal of the Society for Gynecologic Investigation.

[31]  A. Shelling,et al.  Inhibin: a candidate gene for premature ovarian failure. , 2000, Human reproduction.

[32]  A. Murray,et al.  Microdeletions in FMR2 may be a significant cause of premature ovarian failure , 1999, Journal of medical genetics.

[33]  W. Brown,et al.  Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. , 1999, American journal of medical genetics.

[34]  S. Shalet,et al.  Gonadal damage from chemotherapy and radiotherapy. , 1998, Endocrinology and metabolism clinics of North America.

[35]  E. Falkenstein,et al.  Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. , 1996, Biochemical and biophysical research communications.

[36]  C. Tsigos,et al.  Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. , 1996, The New England journal of medicine.

[37]  C. Tsigos,et al.  Testicular and Ovarian Resistance to Luteinizing Hormone Caused by Inactivating Mutations of the Luteinizing Hormone–Receptor Gene , 1996 .

[38]  G. Kaltsas,et al.  Characterization of idiopathic premature ovarian failure , 1996, Fertility and sterility.

[39]  A. Chapelle,et al.  Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure , 1995, Cell.

[40]  H. Zoghbi,et al.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.

[41]  G. Vinson,et al.  Monoclonal antibodies against rat adrenocortical cell antigens. , 1988, Acta endocrinologica.

[42]  J. Annegers,et al.  Incidence of Premature Ovarian Failure , 1986, Obstetrics and gynecology.